Cargando…
Safety of a New Synbiotic Starter Formula
PURPOSE: Breastfeeding is the best way to feed all infants, but not all infants can be (exclusively) breastfed. Cow's milk based infant formula is the second choice infant feeding. METHODS: The safety of a new synbiotic infant formula, supplemented with Bifidobacterium lactis and fructo-oligosa...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636933/ https://www.ncbi.nlm.nih.gov/pubmed/29026733 http://dx.doi.org/10.5223/pghn.2017.20.3.167 |
_version_ | 1783270540923895808 |
---|---|
author | Vandenplas, Yvan Analitis, Antonis Tziouvara, Chara Kountzoglou, Athina Drakou, Anastasia Tsouvalas, Manos Mavroudi, Antigoni Xinias, Ioannis |
author_facet | Vandenplas, Yvan Analitis, Antonis Tziouvara, Chara Kountzoglou, Athina Drakou, Anastasia Tsouvalas, Manos Mavroudi, Antigoni Xinias, Ioannis |
author_sort | Vandenplas, Yvan |
collection | PubMed |
description | PURPOSE: Breastfeeding is the best way to feed all infants, but not all infants can be (exclusively) breastfed. Cow's milk based infant formula is the second choice infant feeding. METHODS: The safety of a new synbiotic infant formula, supplemented with Bifidobacterium lactis and fructo-oligosaccharides, with lactose and a whey/casein 60/40 protein ratio was tested in 280 infants during 3 months. RESULTS: The median age of the infants at inclusion was 0.89 months. Weight evolution was in accordance with the World Health Organization growth charts for exclusive breastfed infants. The evolution of all anthropometric parameters (weight-for-length z score and body mass index-for-age z score) was within the normal range. The incidence of functional constipation (3.2%), daily regurgitation (10.9%), infantile crying and colic (10.5%) were all significantly lower than the reported median prevalence for a similar age according to literature (median value of 7.8% for functional constipation, 26.7% for regurgitation, 17.7% for infantile colic). CONCLUSION: The new synbiotic infant starter formula was safe, resulted in normal growth and was well tolerated. Functional gastro-intestinal manifestations (functional constipation, regurgitation and colic) were significantly lower than reported in literature. Synbiotics (Bifidobacterium lactis and fructo-oligosaccharides) in cow's milk based infant formula bring the second choice infant feeding, formula, closer to the golden standard, exclusive breastfeeding. |
format | Online Article Text |
id | pubmed-5636933 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition |
record_format | MEDLINE/PubMed |
spelling | pubmed-56369332017-10-12 Safety of a New Synbiotic Starter Formula Vandenplas, Yvan Analitis, Antonis Tziouvara, Chara Kountzoglou, Athina Drakou, Anastasia Tsouvalas, Manos Mavroudi, Antigoni Xinias, Ioannis Pediatr Gastroenterol Hepatol Nutr Original Article PURPOSE: Breastfeeding is the best way to feed all infants, but not all infants can be (exclusively) breastfed. Cow's milk based infant formula is the second choice infant feeding. METHODS: The safety of a new synbiotic infant formula, supplemented with Bifidobacterium lactis and fructo-oligosaccharides, with lactose and a whey/casein 60/40 protein ratio was tested in 280 infants during 3 months. RESULTS: The median age of the infants at inclusion was 0.89 months. Weight evolution was in accordance with the World Health Organization growth charts for exclusive breastfed infants. The evolution of all anthropometric parameters (weight-for-length z score and body mass index-for-age z score) was within the normal range. The incidence of functional constipation (3.2%), daily regurgitation (10.9%), infantile crying and colic (10.5%) were all significantly lower than the reported median prevalence for a similar age according to literature (median value of 7.8% for functional constipation, 26.7% for regurgitation, 17.7% for infantile colic). CONCLUSION: The new synbiotic infant starter formula was safe, resulted in normal growth and was well tolerated. Functional gastro-intestinal manifestations (functional constipation, regurgitation and colic) were significantly lower than reported in literature. Synbiotics (Bifidobacterium lactis and fructo-oligosaccharides) in cow's milk based infant formula bring the second choice infant feeding, formula, closer to the golden standard, exclusive breastfeeding. The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition 2017-09 2017-09-26 /pmc/articles/PMC5636933/ /pubmed/29026733 http://dx.doi.org/10.5223/pghn.2017.20.3.167 Text en Copyright © 2017 by The Korean Society of Pediatric Gastroenterology, Hepatology and Nutrition http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Vandenplas, Yvan Analitis, Antonis Tziouvara, Chara Kountzoglou, Athina Drakou, Anastasia Tsouvalas, Manos Mavroudi, Antigoni Xinias, Ioannis Safety of a New Synbiotic Starter Formula |
title | Safety of a New Synbiotic Starter Formula |
title_full | Safety of a New Synbiotic Starter Formula |
title_fullStr | Safety of a New Synbiotic Starter Formula |
title_full_unstemmed | Safety of a New Synbiotic Starter Formula |
title_short | Safety of a New Synbiotic Starter Formula |
title_sort | safety of a new synbiotic starter formula |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636933/ https://www.ncbi.nlm.nih.gov/pubmed/29026733 http://dx.doi.org/10.5223/pghn.2017.20.3.167 |
work_keys_str_mv | AT vandenplasyvan safetyofanewsynbioticstarterformula AT analitisantonis safetyofanewsynbioticstarterformula AT tziouvarachara safetyofanewsynbioticstarterformula AT kountzoglouathina safetyofanewsynbioticstarterformula AT drakouanastasia safetyofanewsynbioticstarterformula AT tsouvalasmanos safetyofanewsynbioticstarterformula AT mavroudiantigoni safetyofanewsynbioticstarterformula AT xiniasioannis safetyofanewsynbioticstarterformula |